Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances
High-grade gliomas (HGG) account for approximately 10% of central nervous system (CNS) tumors in children and 25% of CNS tumors in adults. Despite their rare occurrence, HGG are a significant clinical problem. The standard therapeutic procedure in both pediatric and adult patients with HGG is the su...
Main Authors: | Adrian Kowalczyk, Julia Zarychta, Anna Marszołek, Joanna Zawitkowska, Monika Lejman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/3/623 |
Similar Items
-
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
by: Kristen D. Pawlowski, et al.
Published: (2023-12-01) -
Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
by: Amy J. Petty, et al.
Published: (2020-03-01) -
Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir
by: Madhu C. Choudhary, et al.
Published: (2022-06-01) -
Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland
by: Tomasz J. Ślebioda, et al.
Published: (2022-11-01) -
A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets
by: Hee Young Kang, et al.
Published: (2023-01-01)